2023 Toronto Spatial Biology Roadshow
NanoString Technologies is excited to host our first Toronto Spatial Biology Roadshow hosted at The MaRS Centre! We invite you to an afternoon filled with presentations and discussions all about the future of spatial biology. Join us at our free event and network with spatial biology experts.
Highlights from our speakers:
- Joseph Beechem, PhD, from NanoString Technologies will discuss the future of spatial omics applications and NanoString Technologies’ latest innovations.
- Melanie Spears, PhD, will share her research that used a high-plex RNA assay to detect 1,000 targets simultaneously in situ on a tissue microarray containing breast, colorectal, and bladder cancer using the CosMx Spatial Molecular Imager.
- Christopher McCulloch, PhD, DDS, will describe using the GeoMx Digital Spatial Profiler to identify novel, high probability targets involved in the regulation of mineralizing cells in the process of cementogenesis in mouse jaw bone.
- Gaetano Visconti will highlight Leica Biosystems as your partner in designing optimized, standardized, and automated histopathology workflows in spatial and translational research.
- Lisa Lock, PhD, from Illumina will highlight technologies powered by next-generation sequencing (NGS) from Illumina that can link structural, functional, and spatial insights to enable your next discoveries. Lisa will describe how NGS is used as a readout for NanoString Technologies’ GeoMx Digital Spatial Profiler and how Illumina and NanoString Technologies have partnered to create a streamlined, end-to-end solution for spatial multiomic analysis.
The event will conclude with a networking reception.
Agenda
2:00-4:30 p.m. – Presentations
4:30-6:00 p.m. – Reception
Speakers
Joseph Beechem, PhD, Chief Scientific Officer and Senior Vice President of Research and Development, NanoString Technologies
Spatial-omics Revolution: Innovation Roadmap and Key Applications
Melanie Spears, PhD, Co-director of Diagnostic Development and Principal Research Scientist, Ontario Institute for Cancer Research
Single-cell Characterization of Archival FFPE Tumours with the CosMx Spatial Molecular Imager
Christopher McCulloch, PhD, DDS, Professor, University of Toronto
Application of NanoString Spatial Transcriptomics Platform for Identification of New Targets to Regulate Cell-induced Mineralization
Lisa Lock, PhD, Senior Genomics Specialist, Illumina
Illumina Solutions for Spatial Transcriptomics
Gaetano Visconti, Senior Account Manager (Ontario), Leica Biosystems Canada
Partnering Innovation with Automation: BOND RX research staining instrument provides superior quality and flexibility
Expertise on site
Amir Farooqui, Regional Account Manager, NanoString Technologies
Elizabeth Stirling, PhD, Field Application Scientist, NanoString Technologies
Erroll Rueckert, PhD, Senior District Sales Manager, NanoString Technologies
Marc Peloquin, Account Manager (Quebec), Leica Biosystems Canada
Thanks for attending!
Registration is now closed for this event.
Speakers
Joseph Beechem, PhD
Chief Scientific Officer and Senior Vice President of Research and Development, NanoString
Joseph M. Beechem, PhD, has served as the chief scientific officer and senior vice president of Research and Development at NanoString Technologies since April 2012. He has authored more than 200 peer-reviewed papers, averaging more than four citations each day, in diverse fields such as cancer immunology, infectious disease, imaging, biomathematics, physics, chemistry, spectroscopy, and diagnostics. In addition, Joseph Beechem is named on nearly 50 US patents or patent applications and has served on several editorial and scientific advisory boards. Joseph Beechem received a BS in Chemistry and Biology from Northern Kentucky University and a PhD in Biophysics from Johns Hopkins University.
Melanie Spears, PhD
Co-director of Diagnostic Development and Principal Research Scientist, Ontario Institute for Cancer Research
Melanie Spears, PhD, is the co-director of diagnostic development and principal research scientist at the Ontario Institute for Cancer Research (OICR) in Toronto, Ontario, Canada. She is also an assistant professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. Melanie's focus in translational research seeks to improve the clinical management of patients with breast cancer through biomarker discovery, validation, and assay development using well-annotated clinical cohorts. Her research focuses on quantitative pathology with projects related to predicting response and resistance to both targeted and immune therapy in cancer. Her lab is involved in the use of new high-plex methods including digital spatial profiling (NanoString Technologies) for new biomarker discovery.
Christopher McCulloch, PhD, DDS
Professor, University of Toronto
Christopher McCulloch, PhD, DDS, is professor of dentistry at the University of Toronto and, since 1984, has contributed 335 papers, 150 presentations, and 4 patents that relate to matrix biology and associated diseases of matrix disorders that affect human health. He uses animal models and cultured cells to examine and define fundamental regulatory circuits that define the function and mechanics of connective tissue matrices, particularly in the context of periodontal diseases. As a principal investigator on more than 25 MRC/CIHR research grants, he has developed and employed high-resolution tools to define the contribution of fibroblasts in matrix remodeling in soft connective tissues. He has established a network of collaborators and trainees along with industrial partners to provide optimal support, know-how, and reagents for the conduct of research focusing on how cell-matrix interactions help to define how inflammatory diseases contribute to matrix pathology.
Lisa Lock, PhD
Senior Genomics Specialist, Illumina
Lisa Lock, PhD, has been with Illumina for twelve years as a staff field application scientist and currently as a senior genomics specialist. She obtained her PhD in Biochemistry at McGill University, Montreal, studying molecular oncology, specifically receptor tyrosine kinase signaling in normal versus tumor cells. Prior to Illumina, she did a postdoc at the University of Toronto in cell signaling and worked as a research scientist at Lorus Therapeutics in Toronto developing anti-cancer and anti-microbial therapeutics.
Gaetano Visconti
Senior Account Manager (Ontario), Leica Biosystems Canada
Gaetano Visconti is a former medical laboratory technologist and has over 23 years of sales experience in the field of pathology. In his current role, Gaetano is focused on helping customers with their total pathology solutions and workflow (tissue processing - advanced staining - digital pathology). He covers from the region from the greater Toronto area to Ottawa while working closely with other account managers across Canada.
